Wednesday, February 05, 2025 1:59:17 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent DNA News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 09:04:10 PM
- Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug Discovery • PR Newswire (US) • 05/26/2026 04:33:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/22/2026 07:25:49 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 09:48:36 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/13/2026 02:39:52 PM
- The $59B Quiet Shift Reshaping How Patients Access Care • PR Newswire (Canada) • 05/12/2026 02:30:00 PM
- The $59B Quiet Shift Reshaping How Patients Access Care • PR Newswire (US) • 05/12/2026 02:30:00 PM
- Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab • PR Newswire (US) • 05/07/2026 08:05:00 PM
- Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation • PR Newswire (US) • 04/30/2026 12:01:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/29/2026 08:18:50 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/29/2026 08:10:26 PM
- Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure • PR Newswire (US) • 03/02/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2026 02:56:36 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/26/2026 09:49:34 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/26/2026 09:34:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2026 09:30:45 PM
- Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business • PR Newswire (US) • 02/26/2026 09:26:00 PM
- Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation • PR Newswire (US) • 02/19/2026 01:00:00 PM
- Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-based Agricultural Products • PR Newswire (US) • 02/18/2026 01:00:00 PM
- Ginkgo Bioworks' Autonomous Laboratory Driven by OpenAI's GPT-5 Achieves 40% Improvement Over State-of-the-Art Scientific Benchmark • PR Newswire (US) • 02/05/2026 07:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/04/2026 02:52:31 PM
- Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference • PR Newswire (US) • 01/13/2026 01:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/07/2026 03:09:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/23/2025 10:26:04 PM

